Stanford University School of Medicine, Department of Dermatology, 450 Broadway Street, C 5334, Redwood City, CA 94603, USA.
Genome Med. 2012 Feb 23;4(2):14. doi: 10.1186/gm313.
Cigarette smoking is well-known to associate with accelerated skin aging as well as cardiovascular disease and lung cancer, in large part due to oxidative stress. Because metabolites are downstream of genetic variation, as well as transcriptional changes and post-translational modifications of proteins, they are the most proximal reporters of disease states or reversal of disease states.
In this study, we explore the potential effects of commonly available oral supplements (containing antioxidants, vitamins and omega-3 fatty acids) on the metabolomes of smokers (n = 11) compared to non-smokers (n = 17). At baseline and after 12 weeks of supplementation, metabolomic analysis was performed on serum by liquid and gas chromatography with mass spectroscopy (LC-MS and GC-MS). Furthermore, clinical parameters of skin aging, including cutometry as assessed by three dermatologist raters blinded to subjects' age and smoking status, were measured.
Long-chain fatty acids, including palmitate and oleate, decreased in smokers by 0.76-fold (P = 0.0045) and 0.72-fold (P = 0.0112), respectively. These changes were not observed in non-smokers. Furthermore, age and smoking status showed increased glow (P = 0.004) and a decrease in fine wrinkling (P = 0.038). Cutometry showed an increase in skin elasticity in smokers (P = 0.049) but not in non-smokers. Complexion analysis software (VISIA) revealed decreases in the number of ultraviolet spots (P = 0.031), and cutometry showed increased elasticity (P = 0.05) in smokers but not non-smokers.
Additional future work may shed light on the specific mechanisms by which long-chain fatty acids can lead to increased glow, improved elasticity measures and decreased fine wrinkling in smokers' skin. Our study provides a novel, medicine-focused application of available metabolomic technology to identify changes in sera of human subjects with oxidative stress, and suggests that oral supplementation (in particular, commonly available antioxidants, vitamins and omega-3 fatty acids) affects these individuals in a way that is unique (compared to non-smokers) on a broad level.
众所周知,吸烟会加速皮肤老化,增加心血管疾病和肺癌的风险,这在很大程度上是由于氧化应激。由于代谢物是遗传变异、蛋白质转录变化和翻译后修饰的下游产物,它们是疾病状态或疾病逆转的最接近的报告者。
在这项研究中,我们探索了常用口服补充剂(含抗氧化剂、维生素和欧米伽-3 脂肪酸)对吸烟者(n=11)和非吸烟者(n=17)血清代谢组的潜在影响。在基线和 12 周补充后,通过液相和气相色谱与质谱联用(LC-MS 和 GC-MS)对血清进行代谢组学分析。此外,还测量了皮肤老化的临床参数,包括由三位皮肤科评估员进行的、对受试者年龄和吸烟状况不知情的皮肤光泽度、皮肤弹性和皱纹的评估。
长链脂肪酸,包括棕榈酸和油酸,分别下降了 0.76 倍(P=0.0045)和 0.72 倍(P=0.0112)。这些变化在非吸烟者中没有观察到。此外,年龄和吸烟状况显示皮肤光泽度增加(P=0.004),细小皱纹减少(P=0.038)。吸烟者的皮肤弹性增加(P=0.049),而非吸烟者则没有增加。肤色分析软件(VISIA)显示紫外线斑点数量减少(P=0.031),皮肤弹性增加(P=0.05),这些变化仅在吸烟者中观察到,而非吸烟者则没有。
进一步的研究可能揭示长链脂肪酸如何导致吸烟者皮肤光泽度增加、弹性测量改善和细小皱纹减少的具体机制。我们的研究提供了一种新的、以医学为重点的应用,利用现有的代谢组学技术来识别氧化应激患者血清中的变化,并表明口服补充剂(特别是常用的抗氧化剂、维生素和欧米伽-3 脂肪酸)以一种独特的方式(与非吸烟者相比)影响这些个体,这种影响在广泛的层面上是独特的。